Compare RYTM & MWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RYTM | MWH |
|---|---|---|
| Founded | 2008 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.1B |
| IPO Year | 2017 | 2026 |
| Metric | RYTM | MWH |
|---|---|---|
| Price | $97.07 | $25.47 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 12 |
| Target Price | ★ $131.14 | $35.42 |
| AVG Volume (30 Days) | 421.1K | ★ 1.7M |
| Earning Date | 05-05-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.34 | N/A |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | N/A |
| Revenue This Year | $55.34 | $51.86 |
| Revenue Next Year | $86.06 | $14.78 |
| P/E Ratio | ★ N/A | $236.36 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $74.50 | $23.83 |
| 52 Week High | $122.20 | $48.40 |
| Indicator | RYTM | MWH |
|---|---|---|
| Relative Strength Index (RSI) | 40.64 | 41.31 |
| Support Level | $99.14 | $23.88 |
| Resistance Level | $113.04 | $30.74 |
| Average True Range (ATR) | 3.98 | 1.27 |
| MACD | -0.78 | -0.07 |
| Stochastic Oscillator | 19.75 | 26.04 |
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.
SOLV Energy Inc is a provider of infrastructure services to the power industry, including engineering, procurement, construction, testing, commissioning, operations, maintenance and repowering. It specializes in designing, building and maintaining utility-scale solar and battery storage projects and related T&D infrastructure. The company's projects include: The Eldorado Solar Project, Gravel Pit Solar Project, and Vikings Solar-plus-Storage Project. It operates in one reportable segment which derives revenue through providing EPC, O&M and Development services throughout the Unites Sates. The company derives maximum of revenue from its EPC contracts.